ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.01
0.00%
US Tech 100
18,906.20
-0.02%
S&P 500
5,573.15
-0.74%
US Dollar vs CAD
1.44883
0.40%
Bitcoin
80,065.98
2.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. IN8bio Inc (INAB) Share Price

IN8bio Inc

IN8bio Inc (INAB)

NASDAQ
0.2369
-0.0092
( -3.74% )
Updated: 09:17:09
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.2369
Bid
0.2369
Ask
0.2419
Volume
325,374
0.232 Day's Range 0.2509
0.217 52 Week Range 1.74
Market Cap
17.171M
Previous Close
0.2461
Open
0.2433
Last Trade
500
@
0.2369
Last Trade Time
09:17:09
Financial Volume
US$ 79,385
VWAP
0.24398
Average Volume (3m)
5,919,039
Shares Outstanding
72,483,253
Dividend Yield
-
PE Ratio
-0.58
Earnings Per Share (EPS)
-0.41
Revenue
-
Net Profit
-30.01M

About IN8bio Inc

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.in8bio.com
Headquarters
Wilmington, Delaware, USA
Founded
-
IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was US$0.25. Over the last year, IN8bio shares have traded in a share price range of US$ 0.217 to US$ 1.74.

IN8bio currently has 72,483,253 shares outstanding. The market capitalization of IN8bio is US$17.84 million. IN8bio has a price to earnings ratio (PE ratio) of -0.58.

Ask ADVFN Intelligence (AI)

INAB Latest News

More News

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
March 05 2025
INAB (-3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
March 05 2025
INAB (-3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
March 03 2025
INAB (-3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
February 11 2025
INAB (-3.74%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.016916-6.664670469950.2538160.27470.231614178190.25561438CS
4-0.1631-40.7750.40.41770.2316155334420.30201369CS
12-0.0531-18.31034482760.290.41770.230359190390.30104543CS
26-0.0731-23.58064516130.310.55660.21732368000.31607642CS
52-1.0531-81.63565891471.291.740.21717825110.3919432CS
156-3.0231-92.73312883443.264.97990.21711111471.38456665CS
260-9.7631-97.6311010.3190.2179281571.42956157CS

INAB - Frequently Asked Questions (FAQ)

What is the current IN8bio share price?
The current share price of IN8bio is US$ 0.2369
How many IN8bio shares are in issue?
IN8bio has 72,483,253 shares in issue
What is the market cap of IN8bio?
The market capitalisation of IN8bio is USD 17.84M
What is the 1 year trading range for IN8bio share price?
IN8bio has traded in the range of US$ 0.217 to US$ 1.74 during the past year
What is the PE ratio of IN8bio?
The price to earnings ratio of IN8bio is -0.58
What is the reporting currency for IN8bio?
IN8bio reports financial results in USD
What is the latest annual profit for IN8bio?
The latest annual profit of IN8bio is USD -30.01M
What is the registered address of IN8bio?
The registered address for IN8bio is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the IN8bio website address?
The website address for IN8bio is www.in8bio.com
Which industry sector does IN8bio operate in?
IN8bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SYRSSyros Pharmaceuticals Inc
US$ 0.2661
(190.50%)
357.83M
RAYRaytech Holding Ltd
US$ 1.66
(90.80%)
5.35M
TSVT2seventy bio Inc
US$ 4.93
(76.07%)
20.46M
CUTRCutera Inc
US$ 0.1971
(53.39%)
123.27M
HSAIHesai Group
US$ 22.22
(38.79%)
11.56M
ARVNArvinas Inc
US$ 8.70
(-50.46%)
5.34M
LZMHLZ Technology Holdings Ltd
US$ 8.27
(-47.19%)
201.61k
SPGCSacks Parente Golf Inc
US$ 0.108923
(-31.97%)
18.52M
BDRXBiodexa Pharmaceuticals PLC
US$ 2.06
(-27.72%)
410.43k
ELTKEltek Ltd
US$ 8.25
(-24.35%)
78.49k
SYRSSyros Pharmaceuticals Inc
US$ 0.2661
(190.50%)
357.83M
AWHAspira Womans Health Inc
US$ 0.259434
(31.03%)
147.78M
CUTRCutera Inc
US$ 0.1971
(53.39%)
123.27M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.95
(7.72%)
107.2M
NVDANVIDIA Corporation
US$ 108.72
(1.63%)
80.88M

INAB Discussion

View Posts
LunarMeteor43 LunarMeteor43 4 weeks ago
can you explain that more? I'd like to know what exactly they are doing.
πŸ‘οΈ0
81vette 81vette 4 weeks ago
Watch shares to borrow,when it hits zero with high fee and no rebate,it can go up,until then they are loaning their shares to short and are buying more inside
πŸ‘οΈ0
81vette 81vette 4 weeks ago
Another one with high inst. holding(22%) trans. up 74%,it will run up when they done loading.
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
INAB.............................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
richme richme 4 weeks ago
LSEG Reiterated since 08/25/2021

Strong Buy
LSEG Stocks Plus Report
Latest Report 02/11/2025
LSEG maintains a current price target of $4.04 for INAB
πŸ‘οΈ0
richme richme 4 weeks ago
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
These results are so GREAT that one would expect a higher s/p but ........... maybe a little later.
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
INAB..............................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 5 months ago
INAB....................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 5 months ago
IN8bio Announces Pricing of $12.4 Million Private Placement
πŸ‘οΈ0
BurgerKing82 BurgerKing82 6 months ago
Hello
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TheFinalCD TheFinalCD 6 months ago
$INAB 49% workforce reduction, focusing on INB-100https://t.co/C30I7yWH1v— Michelle Solly (@MSollender) September 4, 2024
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
INAB new 52 week low
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Tyrus603 Tyrus603 11 months ago
Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
πŸ‘οΈ0
Laster Laster 11 months ago
Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.
πŸ‘οΈ0
Invest-in-America Invest-in-America 11 months ago
INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!
πŸ‘οΈ0
glenn1919 glenn1919 1 year ago
INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB under $2
πŸ‘οΈ0
murocman murocman 1 year ago
Surprised how much this has tanked in light of stellar data?

Murocman
πŸ‘οΈ0
murocman murocman 1 year ago
Outstanding data and financing in place to boot!

Should move up!

Murocman
πŸ‘οΈ0
Awl416 Awl416 1 year ago
IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB under $2
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
INAB new 52 week low
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
looks good
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
strong chart
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
reaDY
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
reaDY
πŸ‘οΈ0
Mr Wick Mr Wick 2 years ago
New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
nice
πŸ‘οΈ0
MrMocha MrMocha 2 years ago
I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
👍️ 1
Mr Wick Mr Wick 2 years ago
New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.
👍️ 1
The Night Stalker The Night Stalker 2 years ago
right on
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
strong as hell
πŸ‘οΈ0
Trons Trons 2 years ago
Headed to $20 on cancer developments
πŸ‘οΈ0
Jess070283 Jess070283 2 years ago
Uh oh Shorts I’m trouble….
πŸ‘οΈ0
trendzone trendzone 2 years ago
Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
πŸ‘οΈ0
Jess070283 Jess070283 2 years ago
Loading this dip for the rip…
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
πŸ‘οΈ0
subslover subslover 2 years ago
Love your scanner! :)
πŸ‘οΈ0
2020Benzo 2020Benzo 2 years ago
Did they just post same Orphan Drug news twice in a row it’s sane PR !
πŸ‘οΈ0

Your Recent History

NASDAQ
INAB
IN8bio
TG
C7T
CTT Correios De Portugal
ASX
XCLWBE
Australian Government
NASDAQ
TSAT
Telesat
EU
AUTVL
Amundi Finance Emissions...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads